HKEX:372 stock news
This page provides real-time market news, earnings updates, and company announcements related to PT International Development Corporation Limited (HKEX:372).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-20 09:57 HKT
Zillow Group to Announce First-Quarter 2026 Results May 6
Finviz2026-04-07 20:06:10
Freshworks to Announce First Quarter 2026 Financial Results on May 5, 2026
Finviz2026-04-08 12:03:53
AMD to Report Fiscal First Quarter 2026 Financial Results
Finviz2026-04-08 20:18:41
Costco Wholesale Corporation Reports March Sales Results
Finviz2026-04-08 20:18:39
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
Finviz2026-04-09 11:33:49
Tom Lee's BitMine Uplisted to NYSE as Ethereum Firm Expands Buyback Program to $4 Billion
Decrypt2026-04-09 16:19:02
OpenAI Says Enterprise AI Is Already 40% of Its Revenue Amid ‘Agentic Workflow’ Shift
Decrypt2026-04-09 19:19:02
Airbnb to Announce First Quarter 2026 Results
Finviz2026-04-09 20:06:07
Exponent to Announce First Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on April 30, 2026
Finviz2026-04-09 20:09:47
Clorox Announces April 30 Webcast of Third-Quarter Fiscal Year 2026 Results
Finviz2026-04-09 20:36:06
OpenText to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, May 7, 2026
Finviz2026-04-10 13:03:50
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
Finviz2026-04-10 20:06:48
Semiconductor Q1 2026 Earnings Preview — TSMC 4.16 Investor Conference, ASML Order Verification, NVIDIA 16x P/E Ratio and “Rotation Concerns”
404k2026-04-12 06:19:54
Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
Finviz2026-04-13 10:48:09
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Hippo to Report First Quarter Financial Results on April 30, 2026
Finviz2026-04-13 12:06:08
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
Finviz2026-04-13 13:03:11
PARAMOUNT TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 4, 2026
Finviz2026-04-13 20:03:45
Meta to Announce First Quarter 2026 Results
Finviz2026-04-13 20:06:51
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results
Finviz2026-04-14 20:03:08
Teradata Announces 2026 First Quarter Earnings Release Date
Finviz2026-04-14 20:06:56
Five Star Bancorp Announces First Quarter 2026 Earnings Release Date and Webcast
Finviz2026-04-14 22:33:43
$NVO Novo Nordisk Spring on OpenAI partnership
TradingView2026-04-15 21:15:21
Snap Cuts 1,000 Jobs, Aims to Save $500 Million as AI Reshapes Operations
Decrypt2026-04-16 14:47:16
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
Finviz2026-04-09 11:33:49
Tom Lee's BitMine Uplisted to NYSE as Ethereum Firm Expands Buyback Program to $4 Billion
Decrypt2026-04-09 16:19:02
OpenAI Says Enterprise AI Is Already 40% of Its Revenue Amid ‘Agentic Workflow’ Shift
Decrypt2026-04-09 19:19:02
Airbnb to Announce First Quarter 2026 Results
Finviz2026-04-09 20:06:07
Exponent to Announce First Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on April 30, 2026
Finviz2026-04-09 20:09:47
Clorox Announces April 30 Webcast of Third-Quarter Fiscal Year 2026 Results
Finviz2026-04-09 20:36:06
OpenText to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, May 7, 2026
Finviz2026-04-10 13:03:50
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
Finviz2026-04-10 20:06:48
Semiconductor Q1 2026 Earnings Preview — TSMC 4.16 Investor Conference, ASML Order Verification, NVIDIA 16x P/E Ratio and “Rotation Concerns”
404k2026-04-12 06:19:54
Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
Finviz2026-04-13 10:48:09
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Hippo to Report First Quarter Financial Results on April 30, 2026
Finviz2026-04-13 12:06:08
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
Finviz2026-04-13 13:03:11
PARAMOUNT TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 4, 2026
Finviz2026-04-13 20:03:45
Meta to Announce First Quarter 2026 Results
Finviz2026-04-13 20:06:51
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results
Finviz2026-04-14 20:03:08
Teradata Announces 2026 First Quarter Earnings Release Date
Finviz2026-04-14 20:06:56
Five Star Bancorp Announces First Quarter 2026 Earnings Release Date and Webcast
Finviz2026-04-14 22:33:43
$NVO Novo Nordisk Spring on OpenAI partnership
TradingView2026-04-15 21:15:21
Snap Cuts 1,000 Jobs, Aims to Save $500 Million as AI Reshapes Operations
Decrypt2026-04-16 14:47:16
HKEX:372 stock price change
On the last trading day, HKEX:372 stock closed at 0.23 HKD, with a price change of -11.54% for the day.
Trade stock perpsHKEX:372 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more